PE20000554A1 - 2-aminopiridinas que contienen sustituyentes de anillos condensados - Google Patents
2-aminopiridinas que contienen sustituyentes de anillos condensadosInfo
- Publication number
- PE20000554A1 PE20000554A1 PE1999000464A PE00046499A PE20000554A1 PE 20000554 A1 PE20000554 A1 PE 20000554A1 PE 1999000464 A PE1999000464 A PE 1999000464A PE 00046499 A PE00046499 A PE 00046499A PE 20000554 A1 PE20000554 A1 PE 20000554A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- naphthyl
- phenyl
- piperazine
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Abstract
SE REFIERE A DERIVADOS DE 2-AMINOPIRIDINA DE FORMULA I, DONDE n Y m SON 1-3, UN CARBONO DE LOS ANILLOS OPCIONALMENTE ES SUSTITUIDO POR O, S, N; R1 Y R2 SON ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO CON HALO, NITRO, HIDROXI, ENTRE OTROS; O R1 Y R2 FORMAN JUNTO CON N UN ANILLO DE PIPERAZINA, AZETIDINA, PIPERIDINA, PIRROLIDINA, ANILLO AZABICICLO DE 6-14 MIEMBROS CON 1-3 N; OPCIONALMENTE EL N DE PIPERAZINA, AZABICICLO ESTA SUSTITUIDO POR R3 Y R4; R3 Y R4 SON H, ALQUILO C1-C6, FENILO, NAFTILO, (ALQUILO C1-C6)-CO-, CHO, (ALCOXI C1-C6)-CO-, FENIL-CO-, NAFTIL-CO-, R6R7NCO-; R6 Y R7 SON H, ALQUILO C1-C6, CUANDO EL AZABICICLICO ES ESPIROCICLICO, EL N ESTA SUSTITUIDO POR R5; R5 ES H, ALQUILO C1-C6, FENILO, NAFTILO, FENIL-ALQUILO C1-C6, NAFTIL-ALQUILO C1-C6; ANILLOS DE PIPERAZINA, AZETIDINA, PIPERIDINA Y PIRROLIDINA OPCIONALMENTE SUSTITUIDO CON DE 0-2 ALQUILO C1-C6, AMINO, ALQUILAMINO C1-C6, ENTRE OTROS. UN COMPUESTO PREFERIDO ES 6-[8-(2-DIMETILAMINO-ETOXI)-1,2,3,4-TETRAHIDRO-1,4-METANO-NAFTALEN-5-IL]-PIRIDIN-2-ILAMINA, ENTRE OTROS. EL COMPUESTO I INHIBE A LA OXIDO NITRICO SINTASA POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE MIGRANA, ENFERMEDADES INFLAMATORIAS, ACCIDENTES CEREBROVASCULARES, DOLOR AGUDO Y CRONICO, CHOQUE HIPOVOLEMICO, CHOQUE TRAUMATICO, LESION DE REPERFUSION
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8788198P | 1998-06-03 | 1998-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20000554A1 true PE20000554A1 (es) | 2000-07-08 |
Family
ID=22207822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1999000464A PE20000554A1 (es) | 1998-06-03 | 1999-06-01 | 2-aminopiridinas que contienen sustituyentes de anillos condensados |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP1084109B1 (es) |
JP (1) | JP3444495B2 (es) |
KR (1) | KR20010052515A (es) |
CN (1) | CN1303379A (es) |
AP (1) | AP1208A (es) |
AR (1) | AR016724A1 (es) |
AT (1) | ATE287876T1 (es) |
AU (1) | AU765851B2 (es) |
BG (1) | BG105089A (es) |
BR (1) | BR9911615A (es) |
CA (1) | CA2334012C (es) |
CO (1) | CO5060509A1 (es) |
DE (1) | DE69923448T2 (es) |
DZ (1) | DZ2807A1 (es) |
EA (1) | EA003991B1 (es) |
ES (1) | ES2235475T3 (es) |
GT (1) | GT199900078A (es) |
HR (1) | HRP20000825A2 (es) |
HU (1) | HUP0102236A3 (es) |
ID (1) | ID27027A (es) |
IL (1) | IL139734A0 (es) |
IS (1) | IS5726A (es) |
MA (1) | MA24872A1 (es) |
NO (1) | NO20006042L (es) |
NZ (1) | NZ508057A (es) |
OA (1) | OA11557A (es) |
PA (1) | PA8473501A1 (es) |
PE (1) | PE20000554A1 (es) |
PL (1) | PL344699A1 (es) |
SK (1) | SK17912000A3 (es) |
TN (1) | TNSN99105A1 (es) |
UY (1) | UY25539A1 (es) |
WO (1) | WO1999062883A1 (es) |
YU (1) | YU73200A (es) |
ZA (1) | ZA993699B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010114213A (ko) | 1999-02-25 | 2001-12-31 | 실버스타인 아써 에이. | 접합 고리 치환기를 함유한 2-아미노피리딘 |
GB0004151D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004149D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
GB0004153D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004152D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
PT891332E (pt) * | 1996-03-29 | 2004-07-30 | Pfizer | Derivados de 6-fenilpiridil-2-amina |
BR9811093A (pt) * | 1997-02-10 | 2000-07-18 | Pfizer Prod Inc | Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo) |
HN1998000118A (es) * | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
-
1999
- 1999-05-07 ES ES99915990T patent/ES2235475T3/es not_active Expired - Lifetime
- 1999-05-07 YU YU73200A patent/YU73200A/sh unknown
- 1999-05-07 EP EP99915990A patent/EP1084109B1/en not_active Expired - Lifetime
- 1999-05-07 ID IDW20002508A patent/ID27027A/id unknown
- 1999-05-07 CA CA002334012A patent/CA2334012C/en not_active Expired - Fee Related
- 1999-05-07 NZ NZ508057A patent/NZ508057A/en unknown
- 1999-05-07 WO PCT/IB1999/000825 patent/WO1999062883A1/en not_active Application Discontinuation
- 1999-05-07 OA OA1200000325A patent/OA11557A/en unknown
- 1999-05-07 AT AT99915990T patent/ATE287876T1/de not_active IP Right Cessation
- 1999-05-07 AU AU34387/99A patent/AU765851B2/en not_active Ceased
- 1999-05-07 PL PL99344699A patent/PL344699A1/xx unknown
- 1999-05-07 EA EA200001143A patent/EA003991B1/ru not_active IP Right Cessation
- 1999-05-07 BR BR9911615-4A patent/BR9911615A/pt not_active Application Discontinuation
- 1999-05-07 DE DE69923448T patent/DE69923448T2/de not_active Expired - Fee Related
- 1999-05-07 SK SK1791-2000A patent/SK17912000A3/sk unknown
- 1999-05-07 IL IL13973499A patent/IL139734A0/xx unknown
- 1999-05-07 HU HU0102236A patent/HUP0102236A3/hu unknown
- 1999-05-07 KR KR1020007013655A patent/KR20010052515A/ko not_active Application Discontinuation
- 1999-05-07 JP JP2000552095A patent/JP3444495B2/ja not_active Expired - Fee Related
- 1999-05-07 CN CN99806847A patent/CN1303379A/zh active Pending
- 1999-05-19 PA PA19998473501A patent/PA8473501A1/es unknown
- 1999-06-01 ZA ZA9903699A patent/ZA993699B/xx unknown
- 1999-06-01 GT GT199900078A patent/GT199900078A/es unknown
- 1999-06-01 PE PE1999000464A patent/PE20000554A1/es not_active Application Discontinuation
- 1999-06-01 AR ARP990102581A patent/AR016724A1/es not_active Application Discontinuation
- 1999-06-02 MA MA25606A patent/MA24872A1/fr unknown
- 1999-06-02 DZ DZ990107A patent/DZ2807A1/xx active
- 1999-06-02 TN TNTNSN99105A patent/TNSN99105A1/fr unknown
- 1999-06-03 UY UY25539A patent/UY25539A1/es not_active Application Discontinuation
- 1999-06-03 CO CO99035001A patent/CO5060509A1/es unknown
- 1999-06-03 AP APAP/P/1999/001558A patent/AP1208A/en active
-
2000
- 2000-11-24 IS IS5726A patent/IS5726A/is unknown
- 2000-11-29 NO NO20006042A patent/NO20006042L/no not_active Application Discontinuation
- 2000-11-30 HR HR20000825A patent/HRP20000825A2/hr not_active Application Discontinuation
- 2000-12-22 BG BG105089A patent/BG105089A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE55098A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
CO4700455A1 (es) | Derivados tetraciclicos y proceso para su preparacion | |
PE20020228A1 (es) | Compuestos organicos como inhibidores de 3',5' guanosin monofosfato ciclico fosfodiesterasa | |
UY25158A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
IT1251376B (it) | Pregna 1,4-diene-3,20-dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori | |
ES2052675T3 (es) | 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos. | |
PE20000554A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
AR012870A1 (es) | Derivados de ergolina ([6ar, 9r, 10ar]-6-[4-(5-bromo-7-metil-4,6,6a,7,8,9, 10,10a-octahidro-indol[4,3-fg]quinolin-9-carbonil)-piperazin-1-il]-1-metil-1h-piridin-2-ona), proceso para su produccion, composicion farmaceutica, y su uso para la fabricacion de un medicamento para el tratamiento de depresi | |
AR010331A1 (es) | Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos. | |
RO80265B (ro) | Procedeu pentru prepararea unor derivati de acid beta-carbolin-3-carboxilic | |
ES2097659T3 (es) | Derivados antimitoticos de los alcaloides binarios del catharanthus roseus. | |
PE20030848A1 (es) | Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1 | |
AR064517A1 (es) | Pirimidinionas biciclicas y sus usos | |
DK716188D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
SE7713471L (sv) | Nya organiska foreningar, deras framstellning och anvendning | |
AR016644A1 (es) | Compuestos de 2-aminopiridinas con sustituyentes alcoxi ramificados, composicion farmaceutica y uso para la manufactura de medicamentos | |
MY102762A (en) | Novel organic compounds and their pharmaceutical use. | |
DE3778396D1 (de) | 1h-imidazol-5-carbonsaeurederivate. | |
ES2154605B1 (es) | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 | |
PE20080126A1 (es) | Metodos para tratar trastornos cognitivos y otros afines | |
AR247380A1 (es) | Procedimiento para preparar derivados de n-aminobutil n-fenil arilamidas | |
DK43683D0 (da) | Aromatiske forbindelser med antihistamin-aktivitet, fremgangsmade til deres fremstilling samt deres anvendelse | |
AR006991A1 (es) | Analogo hidrosoluble de 20(s)- camptotecina, una composicion farmaceutica que los contiene, una medicina para el tratamiento del cancer, leucemia oestados relacionados con el hiv, el uso de dichos compuestos y un procedimiento para su preparacion | |
AR013152A1 (es) | Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n. | |
ES401710A1 (es) | Procedimiento para la preparacion de nuevos compuestos bi- ciclicos nitrogenados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |